Holen Sie sich die Stockscreener-App
21.24
3.06%
0.63
Vorhandelsmarkt:
21.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$20.61
Offen:
$20.88
24-Stunden-Volumen:
1.72M
Relative Volume:
0.87
Marktkapitalisierung:
$1.46B
Einnahmen:
$1.01B
Nettoeinkommen (Verlust:
$-204.71M
KGV:
-6.9206
EPS:
-3.0691
Netto-Cashflow:
$-29.67M
1W Leistung:
+5.67%
1M Leistung:
-14.42%
6M Leistung:
+36.68%
1J Leistung:
+25.98%
1-Tages-Spanne:
$20.79
$21.86
1-Wochen-Bereich:
$20.01
$21.96
52-Wochen-Spanne:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
21.24 | 1.41B | 1.01B | -204.71M | -29.67M | -3.0691 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-19 | Hochstufung | Truist | Hold → Buy |
| 2026-03-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | Hochstufung | Lake Street | Hold → Buy |
| 2026-02-20 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-01-27 | Fortgesetzt | TD Cowen | Buy |
| 2025-12-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | Fortgesetzt | Stifel | Hold |
| 2025-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
A Look at Tandem Diabetes Care Inc (TNDM) After 3.0% Gain -- GF Value $33.02 vs Price $21.24 - GuruFocus
TNDM Maintained by TD Cowen -- Price Target Raised to $28.00 - GuruFocus
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $28 - Moomoo
Tandem Diabetes stock price target raised to $28 by TD Cowen - Investing.com Canada
TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $28 - Moomoo
Tandem Diabetes Care Opens with 5.69% Gain, Outpacing S&P 500's 2.51% Increase - Markets Mojo
Tandem Diabetes (TNDM) COO exercises RSUs; shares withheld for taxes - Stock Titan
Tandem Diabetes Care Inc (TNDM) Shares Surge 4.8% -- What GF Score of 74 Tells Investors - GuruFocus
Mizuho Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $22 - Moomoo
Ideas Watch: Can Tandem Diabetes Care Inc continue delivering strong returnsPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Does Tandem Diabetes Care Inc have pricing power2026 Weekly Recap & Daily Momentum Trading Reports - baoquankhu1.vn
(TNDM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Pharma News: Is Tandem Diabetes Care Inc forming bullish engulfing patternsTrade Volume Report & Pattern Based Trade Signal System - baoquankhu1.vn
Rep. Cisneros Buys Tandem Diabetes Care Shares - National Today
Panic Selling: How is Tandem Diabetes Care Inc managing supply chain issues2026 Closing Moves & High Accuracy Buy Signal Tips - baoquankhu1.vn
Aug Catalysts: Should I hold or sell Tandem Diabetes Care Inc now2026 Reactions & High Win Rate Trade Alerts - baoquankhu1.vn
Looking Ahead: Key Trends Shaping the Diabetes Care Market Until 2030 - openPR.com
Goldman Sachs Lowers Price Target for Tandem Diabetes Care (TNDM) to $25 | TNDM Stock News - GuruFocus
Travel Stocks: Can Tandem Diabetes Care Inc continue delivering strong returns - baoquankhu1.vn
Artificial Pancreas System Market to Hit US$ 2,070.82 Million - openPR.com
TNDM Stock Chart | TANDEM DIABETES CARE INC (NASDAQ:TNDM) - ChartMill
[ARS] TANDEM DIABETES CARE INC SEC Filing - Stock Titan
Avoid These 3 Stocks Under $50: Financial Risks Analyzed | 2026News and Statistics - IndexBox
The Bull Case For Tandem Diabetes Care (TNDM) Could Change Following JPMorgan’s Stake Cut And Ongoing Selloff - Sahm
Tandem Diabetes Care (NASDAQ: TNDM) seeks approval for equity plan, charter changes - Stock Titan
Tandem Diabetes (TNDM) Positioned for Potential Upside Post Q1 R - GuruFocus
Smart Insulin Management Devices Market is expected to Hit US$ - openPR.com
Diabetes device recall surge reveals a worrying information gap - Modern Healthcare
TNDM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN
Market Outlook: Will Tandem Diabetes Care Inc benefit from AI trends2026 Sector Moves & Technical Buy Zone Confirmation - baoquankhu1.vn
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - Yahoo Finance
Tandem Diabetes adds Android support for Mobi insulin pump - Investing.com
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
JPMorgan Chase Reduces Stake in Tandem Diabetes Care - National Today
JPMorgan Chase & Co. Sells 203,183 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care Stock Plummets 26% With 8-Day Losing Streak - Trefis
Tandem Diabetes Care Stock Slides -26% With A 8-Day Losing Spree - Trefis
Tandem Diabetes Care to Announce Q1 2026 Results on May 7 - National Today
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves - Sahm
Tandem Diabetes Care Stock In Shambles: Down 25% With 7-Day Losing Streak - Trefis
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Earnings Report: Should value investors consider Tandem Diabetes Care Inc2026 Top Decliners & Fast Momentum Entry Tips - baoquankhu1.vn
Tandem Diabetes Care Stock Hits Day Low Amid Price Pressure at $20.93 - Markets Mojo
TNDM SEC FilingsTandem Diabetes 10-K, 10-Q, 8-K Forms - Stock Titan
Tandem Diabetes and Roche Reach a Patent Settlement - MSN
Board asks shareholders to approve 3.26M-share increase; TNDM files proxy (TNDM) - Stock Titan
Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6%Time to Sell? - MarketBeat
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):